← All trials
NCT05100264
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 25, 2021
- Primary completion
- Nov 1, 2022
- Completion date
- Dec 1, 2022
- First posted
- Oct 29, 2021
- Last posted
- Oct 29, 2021
- Enrollment
- 200
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Alexandra Hospital, Athens, GreeceLead sponsor
- University of AthensCollaborator
- Alexandra Hospital, Athens, GreeceReponsible party - principal investigator
- Alexandra General HospitalStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.